Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019_ randomised controlled trial Auteur/autrice de la publication :Admin Post published:23 janvier 2021 Post category:COVID 19 Effect-of-tocilizumab-on-clinical-outcomes-at-15-days-in-patients-with-severe-or-critical-coronavirus-disease-2019_-randomised-controlled-trialTélécharger Vous devriez également aimer Reinfection with two genetically distinct SARS‐CoV‐2 viruses within 19 days 3 juillet 2021 Vaccine-Induced Myocarditis Concerns Demand Respect, Not Absolutism 8 juillet 2021 National surveillance of bacterial and fungal co- and secondary infection in COVID-19 patients in England – Lessons from the first wave 3 juillet 2021
National surveillance of bacterial and fungal co- and secondary infection in COVID-19 patients in England – Lessons from the first wave 3 juillet 2021
